Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Nano-X Imaging Ltd.

NNOX · Nasdaq · CIK 0001795251 · Healthcare · Medical Devices

INSIDER SIGNAL

59.4 / 100

3 buyers · 9 purchase transaction lines · $179.4K gross purchase

WHY THIS SIGNAL?

Buyer breadthModerate
Purchase sizeLow
RoleModerate
RecencyModerate
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+21.0 / 35
Purchase size+9.7 / 25
Role+13.0 / 20
Recency+5.8 / 10
Conviction+9.9 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Meltzer ErezChief Executive Officer
●●●●
Suesskind Dan SDirector
●●
Alroy ErezDirector
▼
Daniel RanCFO
○
Kainan NogaDirector
●
Aharon Cohen TamarEVP & Chief Marketing Officer
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS3
PURCHASE CONCENTRATION51%Largest buyer: Suesskind Dan S · $91.8K
CLUSTER BUYING · 15D3 insidersPeak activity: 2026-07-27–2026-08-10

Roles in the peak window: Chief Executive Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

59.4 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 60.0
  2. 59.9
  3. 59.8
  4. 59.6
  5. 59.4

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

9Purchases
2Sales
9Other Form 4 lines
17SEC filings · 365 days
BUYING9 qualifying P line(s) · 180 days
SELLING2 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-26.3%
3M
-48.8%
6M
-76.3%
12M
-87.6%

Volatility & liquidity

Volatility
88.3%
Beta
—
Avg daily value
USD 619,052

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-576.1%
ROE
-53.7%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
6,303,398
Previous report
6,760,532
Avg daily volume
896,007
Days to cover
7.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-15Meltzer ErezPurchase (P)Ordinary Shares10,000USD 0.69USD 6,900SEC filing ↗
2026-09-14Suesskind Dan SPurchase (P)Ordinary Shares60,000USD 0.76USD 45,300SEC filing ↗
2026-09-10Meltzer ErezPurchase (P)Ordinary Shares10,000USD 0.78USD 7,800SEC filing ↗
2026-08-10Meltzer ErezPurchase (P)Ordinary Shares9,443USD 1.03USD 9,726SEC filing ↗
2026-07-28Kainan NogaPurchase (P)Ordinary Shares33,000USD 0.90USD 29,700SEC filing ↗
2026-07-27Suesskind Dan SPurchase (P)Ordinary Shares50,000USD 0.93USD 46,500SEC filing ↗
2026-07-27Meltzer ErezPurchase (P)Ordinary Shares36,000USD 0.93USD 33,480SEC filing ↗
2025-09-05Daniel RanPurchase (P)Ordinary shares1,000USD 3.65USD 3,650SEC filing ↗

Form 4 evidence

20 transaction lines in the latest 365-day window; 21 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14saban sharonAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-14Yahav Attias GaliAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-14Nathansohn GuyAward / grant (A)Ordinary Shares50,000USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (17 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-14saban sharonAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-14Yahav Attias GaliAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-14Nathansohn GuyAward / grant (A)Ordinary Shares50,000USD 0.00USD 0SEC filing ↗
2026-10-13Gofman Feler MarinaAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-11Dara JamesAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-11Aharon Cohen TamarAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-10-10Koren OfirAward / grant (A)Ordinary Shares28,283USD 0.00USD 0SEC filing ↗
2026-09-15Meltzer ErezPurchase (P)Ordinary Shares10,000USD 0.69USD 6,900SEC filing ↗
2026-09-14Suesskind Dan SPurchase (P)Ordinary Shares60,000USD 0.76USD 45,300SEC filing ↗
2026-09-10Meltzer ErezPurchase (P)Ordinary Shares10,000USD 0.78USD 7,800SEC filing ↗
2026-08-10Meltzer ErezPurchase (P)Ordinary Shares9,443USD 1.03USD 9,726SEC filing ↗
2026-07-29Daniel RanD (D)Ordinary Shares1,000USD 0.89USD 890SEC filing ↗
2026-07-28Kainan NogaPurchase (P)Ordinary Shares33,000USD 0.90USD 29,700SEC filing ↗
2026-07-27Suesskind Dan SPurchase (P)Ordinary Shares50,000USD 0.93USD 46,500SEC filing ↗
2026-07-27Meltzer ErezPurchase (P)Ordinary Shares36,000USD 0.93USD 33,480SEC filing ↗
2026-06-10Alroy ErezSale (S)Ordinary Shares678USD 1.65USD 1,119SEC filing ↗
2026-03-18Daniel RanD (D)Ordinary shares39,474USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerNNOX
CIK0001795251
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history21 transaction lines from 2025-09-05 to 2026-10-14
10 P purchase lines · 2 S sale lines · 9 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.